Did not become law. It stopped in the House of Representatives's General Law Committee on February 2, 2017. The 2017 session has ended.
2017 Regular Session
House Bill 5732
AN ACT CONCERNING THE LABELING OF PRESCRIPTION DRUG CONTAINERS CONTAINING OPIATES.
What it does
The synopsis the General Assembly published with the bill.
To inform patients regarding the potency and possible negative consequences of taking prescription opiate drugs.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the House of Representatives
Sponsor
4 co-sponsors
Ezequiel Santiago, Geraldo C. Reyes Jr., Bruce V. Morris, Josh Elliott
Its course
January 17 to February 2, 2017, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action2 actions on 2 days
In the House of RepresentativesJan 17 to Feb 2 · stopped16 days
General Law CommitteeJan 17 to Feb 2 · stopped16 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the House of Representatives Jan 17 – Feb 2
- Jan 17Introduced and sent to General Law Committee
- Feb 2Heard in General Law Committee
All 2 actions, as published
- Jan 17REF. TO JOINT COMM. ONBoth houses
- Feb 2PUBLIC HEARINGBoth houses